UFPT on Nasdaq

UFP Technologies

American health care product manufacturer

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

1963Founded1

Compare with Bioventus Inc., NovoCure Ltd or AtriCure (United States), or pick any stock.

  • TickerUFPT on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersGeorgetown1
  • Websitewww.ufpt.com
  • Legal formDelaware corporation1
  • Incorporated inDE5
  • Business address100 Hale Street, Newburyport, Ma 019505
  • Filer categoryLarge accelerated filer5
  • LEI549300RJ8LY41HS70C914
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered address251 LITTLE FALLS DRIVE, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 23553794

See how the biggest companies compare on our leaderboards

UFPT Logo CMYK -«
Photo: Jbodoh, CC BY-SA 4.0, via Wikimedia Commons7

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

28.3%Gross margin8
15.3%Operating margin8
11.3%Net margin8
19.5%Revenue growth, 20258
16.1%Return on equity8
0.29×Debt to equity8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 98% of the revenue UFP Technologies broke down this way in fiscal 2025.

  1. Product$591.4M898%up 20% from 2024
  2. Engineering And Development$6.9M81%up 47% from 2024
  3. Tooling And Machinery$4.5M81%down 46% from 2024
Products and services by year
Products and services202320242025
Product$391.5M$491.4M$591.4M
Engineering And Development$5.1M$4.7M$6.9M
Tooling And Machinery$3.5M$8.3M$4.5M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue72¢$432.4M
  • Research and development1¢$8.6M
  • Selling, general and admin13¢$77.4M
  • Income tax2¢$14.2M
  • Profit11¢$68.3M

Out of $602.8M in revenue.8

Where each dollar of operating cash went, fiscal 2025

  • Kept or used elsewhere100¢$91.9M

Out of $91.9M of cash from operations.8

Financial statements

Revenue91011128$602.8M in 2025+204% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $198.4M$198.4M20192020: $179.4M$179.4M2020−10%2021: $206.3M$206.3M2021+15%2022: $353.8M$353.8M2022+71%2023: $400.1M$400.1M2023+13%2024: $504.4M$504.4M2024+26%2025: $602.8M$602.8M2025+20%
Gross profit91011128$170.4M in 2025+216% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $54.0M$54.0M20192020: $44.7M$44.7M2020−17%2021: $51.1M$51.1M2021+14%2022: $90.3M$90.3M2022+77%2023: $112.2M$112.2M2023+24%2024: $146.7M$146.7M2024+31%2025: $170.4M$170.4M2025+16%
Operating income91011128$92.3M in 2025+274% since 2019
0$25.0M$50.0M$75.0M$100.0M2019: $24.7M$24.7M20192020: $16.7M$16.7M2020−32%2021: $21.2M$21.2M2021+27%2022: $55.4M$55.4M2022+161%2023: $57.7M$57.7M2023+4%2024: $80.9M$80.9M2024+40%2025: $92.3M$92.3M2025+14%
Net income91011128$68.3M in 2025+246% since 2019
0$20.0M$40.0M$60.0M$80.0M2019: $19.8M$19.8M20192020: $13.4M$13.4M2020−32%2021: $15.9M$15.9M2021+19%2022: $41.8M$41.8M2022+163%2023: $44.9M$44.9M2023+8%2024: $59.0M$59.0M2024+31%2025: $68.3M$68.3M2025+16%

Every line of the income statement as filed: the last 3 fiscal years (annual) or 12 quarters (quarterly), latest first.8

Period ending2025-12-312024-12-312023-12-31
Net sales$602.8M$504.4M$400.1M
Cost of sales$432.4M$357.7M$287.8M
Gross profit$170.4M$146.7M$112.2M
Selling, general, and administrative expenses$77.4M$62.2M$50.9M
Acquisition costs$334.0K$2.5M$0
Change in fair value of contingent consideration$261.0K$952.0K$3.5M
Loss on disposal of property, plant and equipment$38.0K$106.0K$145.0K
Operating income$92.3M$80.9M$57.7M
Interest expense, net$9.8M$8.1M$3.6M
Other expense (income)$21.0K-$189.0K$117.0K
Income before income tax provision$82.5M$73.0M$53.9M
Income tax expense$14.2M$14.0M$9.0M
Basic (in dollars per share)$8.87$7.69$5.89
Diluted (in dollars per share)$8.75$7.58$5.83
Basic (in shares)7.7M shares7.7M shares7.6M shares
Diluted (in shares)7.8M shares7.8M shares7.7M shares
Net income$68.3M$59.0M$44.9M
Foreign currency translation adjustment$7.9M-$4.4M$878.0K
Other comprehensive income (loss)$7.9M-$4.4M$878.0K
Comprehensive income$76.2M$54.5M$45.8M

Compare UFP Technologies with another company

The story

1963-1975

United Packaging Corporation was founded in 1963 by William H. Shaw, Robert W. Drew, and Richard L. Bailly in Woburn, MA as a manufacturer of protective packaging, primarily for electronics. In 1964, the company expanded operations and moved its factory headquarters to Georgetown, Massachusetts. In 1967, the company changed its name to United Foam Plastics Corporation to reflect a broader market capability.

1976-1983

In 1976, with a focus on foam fabrication, the company started precision molding cross-linked polyethylene foam components for the military, consumer, and industrial markets.

1984-1993

In 1988 UFP Technologies introduced compression molded medical protective packaging using specialized foams. On December 17, 1993 the company completed its IPO and formally changed its name to UFP Technologies, Inc. Acquisitions brought new, highly specialized materials including various foams, films, and fabrics used in a range of medical, military, aerospace, consumer, and automotive applications. Additionally, UFP added molded pulp packaging to its portfolio through the acquisition of Moulded Fibre Technology out of Portland, ME.

1994-2003

UFP's growing medical customer base prompted its investment in cleanroom production starting in 1994. In 2001 the company introduced thermoplastic polyurethane (TPU) based pouches and bags as an alternative to foam packaging for the orthopedic implant market. Additional acquisitions expanded its medical foams access and capabilities for a range of applications.

Read the full text

2004-2013

UFP continued to focus on the medical market, accounting for 50% of its $100 million revenue by 2008. Between 2008 and 2013, UFP made five acquisitions to continue its foam offering to medical clients. In 2013 the company introduced a new product line called FlexShield®, a TPU based packaging solution for medical devices, instruments, and orthopedic implants.

2014-2024

In 2016 UFP expanded operations and relocated its headquarters to Newburyport, Massachusetts. In 2022 UFP Technologies sold Molded Fiber Business to CKF, Inc.

In 2022 Sales exceeded $300 million and the firm opened a new medical manufacturing operation in Tijuana, Mexico. In 2023, UFP Technologies was added to the S&P SmallCap 600 index. Additional MedTech acquisitions expanded UFP's international footprint to 5 countries and added complete device manufacturing capabilities. As of 2024, its MedTech business accounted for over 90% of revenue.

From Wikipedia’s article on UFP Technologies, shared under CC BY-SA 4.0.6

Leadership

Who has led UFP Technologies, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. R. Jeffrey Bailly2006–now

Chair

  1. R. Jeffrey Bailly2026–now

President

  1. R. Jeffrey Bailly2006–now

Chief financial officer

  1. Ronald J. Lataille2006–now
197019801990200020102020
Board members and other officers (18)

Acquisitions

1993 - Moulded Fibre Technology

1997 - FCE Industries

1998 - Pacific Foam Technologies

2000 – Simco Industries

Read the full text

2008 - Stephenson & Lawyer

2009 - Advanced Materials Group

2009 - Foamade Industries Inc.

2009 - E.N. Murray

2013 - Packaging Alternatives Corporation

2018 – Dielectrics

2021 - Contech Medical

2021 – DAS Medical

2022 - Advant Medical

2024 - AJR Enterprises

2024 - AQF Medical

2024 - Marble Medical

2024 - Welch Fluorocarbon

2025 - UNIPEC

2025 - Techno Plastics Industries, Inc. (TPI)

From Wikipedia’s article on UFP Technologies, shared under CC BY-SA 4.0.6

Timeline

  1. Jan 4, 2006New chief executive R. Jeffrey Bailly becomes CEO16
  2. Dec 17, 1993Went public Listed on NASDAQ1
  3. 1963Founded Founded1

Filings

336 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 64 major events, 173 insider forms, 28 large holders, 50 other. The latest 20:

  1. Oct 9, 2026SCHEDULE 13G/A EDGAR
  2. Aug 27, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  3. Aug 25, 2026144 EDGAR
  4. Aug 24, 20268-K 8-K RE INVESTOR PRESENTATION EDGAR
  5. Aug 19, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  6. Aug 17, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Aug 17, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  8. Aug 17, 2026144/A EDGAR
  9. Aug 14, 2026144 EDGAR
  10. Aug 13, 2026144 EDGAR
  11. Aug 12, 20264/A EDGAR
  12. Aug 11, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Aug 10, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  14. Aug 7, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Aug 6, 2026144 EDGAR
  16. Aug 6, 2026144 EDGAR
  17. Aug 6, 202610-Q EDGAR
  18. Aug 6, 2026144 EDGAR
  19. Aug 3, 20268-K EDGAR
  20. Jul 31, 2026SCHEDULE 13G EDGAR

The 336 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

72 open-market trades by officers, directors and large owners since October 2021: 3 buys and 69 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 25, 2026KOZIN MARC DDirectorSale7,000$304.50$2.1MForm 4
Aug 18, 2026Hudson SymeriaDirectorSale298$319.11$95.1KForm 4
Aug 14, 2026Hudson SymeriaDirectorSale1,926$324.58$625.1KForm 4
Aug 13, 2026FELDMANN CYNTHIA LDirectorSale1,000$324.26$324.3KForm 4
Aug 10, 2026BAILLY R JEFFREYExecutive ChairmanSale13,011$316.13$4.1MForm 4
Aug 7, 2026BAILLY R JEFFREYExecutive ChairmanSale5,013$317.87$1.6MForm 4
Aug 6, 2026BAILLY R JEFFREYExecutive ChairmanSale10,682$318.63$3.4MForm 4
Aug 6, 2026Holt JasonVice PresidentSale1,100$317.00$348.7KForm 4
Jun 12, 2026FELDMANN CYNTHIA LDirectorSale1,200$239.29$287.1KForm 4
May 12, 2026CROTEAU DANIEL CDirectorSale2,864$221.71$635.0KForm 4
Dec 10, 2025Holt JasonVice PresidentSale100$213.58$21.4KForm 4
Nov 6, 2025Litterio Christopher P.Senior Vice PresidentSale1,829$227.20$415.6KForm 4
Sep 5, 2025CROTEAU DANIEL CDirectorSale2,873$206.02$591.9KForm 4
May 8, 2025Litterio Christopher P.Senior Vice PresidentSale1,473$220.12$324.2KForm 4
Feb 28, 2025FELDMANN CYNTHIA LDirectorSale2,756$230.72$635.9KForm 4
Feb 27, 2025CROTEAU DANIEL CDirectorSale6,846$228.41$1.6MForm 4
Feb 27, 2025LATAILLE RONALD JChief Financial OfficerBuy400$229.09$91.6KForm 4
Nov 13, 2024BAILLY R JEFFREYExecutive ChairmanSale2,488$345.70$860.1KForm 4
Nov 12, 2024Holt JasonVice PresidentSale146$342.69$50.0KForm 4
Nov 12, 2024BAILLY R JEFFREYExecutive ChairmanSale12,533$346.46$4.3MForm 4

All 72 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.1,141,410$302.6M0.0%+44,227
Congress Asset Management Co687,439$182.3M1.1%+164,001
Wasatch Advisors LP683,262$181.2M1.2%−94,051
Neuberger Berman Group LLC537,038$142.4M0.1%+236,445
Boston Trust Walden Corp336,278$89.2M0.7%+19,206
Vanguard Capital Management LLC329,623$87.4M0.0%+2,898
State Street Corp312,811$82.9M0.0%+9,498
American Century Companies Inc279,976$74.2M0.0%+154,116
UBS Group AG254,740$67.5M0.0%+81,000
Massachusetts Financial Services Co /ma/223,474$59.2M0.0%−3,829
Geode Capital Management, LLC200,933$53.3M0.0%+10,313
Allspring Global Investments Holdings, LLC195,720$52.6M0.1%+5,857
Dimensional Fund Advisors LP186,313$49.4M0.0%+6,340
Vanguard Portfolio Management LLC161,218$42.7M0.0%+9,457
AltraVue Capital, LLC147,466$39.1M2.8%−6,600
Annex Advisory Services, LLC130,481$34.6M0.6%+87
Morgan Stanley124,387$33.0M0.0%−4,193
Franklin Resources Inc114,068$30.2M0.0%+31,920
Swedbank AB105,505$28.0M0.0%−9,500
Ashford Capital Management Inc105,020$27.8M3.0%−2,990
Geneva Capital Management LLC103,038$27.3M0.6%−28,135
Envestnet Asset Management Inc98,347$26.1M0.0%−11,444
Northern Trust Corp91,260$24.2M0.0%+4,860
Neumeier Poma Investment Counsel LLC84,575$22.4M1.5%+33,720
Renaissance Technologies LLC84,465$22.4M0.0%−22,007

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44